| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |